PepsiCo Keeping Close Eye on Weight Loss Drugs' Potential Impact on Snack Sales

PepsiCo CEO says weight loss drugs haven't hurt their business yet, but they're monitoring the potential impact.

These drugs could change people's eating habits long-term if widely adopted, so food companies need to prepare.

PepsiCo has already been reworking portfolio for smaller sizes and healthier options that could help if the drugs reduce consumption.

CFO says the drugs could even be positive if they improve human health, though snacking will continue.

Price hikes have boosted PepsiCo's bottom line recently, and the company raised its earnings outlook for the third straight quarter.